Leopoldo Aguilera-Aguirre

Leopoldo Aguilera-Aguirre has extensive experience in the field of biosciences and research. Leopoldo is currently employed as the Principal Research Scientist at Yuva Biosciences, Inc. since April 2020. Prior to this, they worked at The University of Texas Medical Branch at Galveston for a significant amount of time.

At the university, Leopoldo held various research roles. From December 2016 to April 2020, they served as a Research Scientist I, where they focused on host-pathogen interactions and innate immune responses to viruses. Their work included investigating the role of members of the tripartite motif family of E3-ubiquitin ligases in inflammatory processes associated with viral infections. Leopoldo also studied oxidative stress-induced DNA damage/repair-mediated cell signaling, cytokine gene expression, and tissue remodeling during inflammation.

Before their role as a Research Scientist I, Leopoldo held the position of Postdoctoral Trainee V from January 2015 to November 2016. As a Postdoctoral Fellow from November 2009 to December 2014, they conducted research in the same field. Leopoldo began their research career at the university as a Research Associate I and II from June 2005 to October 2009.

Overall, Leopoldo's work experience highlights their expertise and dedication to studying host-pathogen interactions, innate immune responses, and inflammatory processes related to viral infections.

Leopoldo Aguilera-Aguirre began their education by obtaining a Bachelor's Degree in Biology, General from Universidad Michoacana de San Nicolás de Hidalgo, which they completed from 1987 to 1996. Leopoldo then pursued a Master's Degree in Experimental Biology from the same university, which they completed from 1998 to 2000. Leopoldo further advanced their education by pursuing a Doctor of Philosophy (Ph.D.) in Biological Sciences/Experimental Biology from Universidad Michoacana de San Nicolás de Hidalgo, which they completed from 2006 to 2009. Finally, they pursued a Postdoctorate degree in Immunology and Molecular Biology from The University of Texas Medical Branch, which they began in 2009 and is still ongoing.